Bone Marrow & Stem Cell Transplant
The Bone Marrow and Stem Cell Transplant Program at Weill Cornell Medicine was established with the mission of providing the best care and most innovative research in a compassionate and comfortable environment.
We take a multidisciplinary approach to care for patients with cancer and blood diseases who need stem cell transplants, providing world-class clinical care in collaboration with experts in leukemia, lymphoma, myeloma and other blood disorders. Based at NewYork-Presbyterian/Weill Cornell Medical Center, one of the top ten general hospitals in the nation, the expertise of our consulting team is unsurpassed.
Our patients and families cope with life-threatening illness; as such, sensitivity and compassion are a priority for our team. We view each patient as an individual, and our approach ensures that each treatment regimen is narrowly tailored to meet the unique, changing needs of our patients and their families – before, during and after transplant.
As New York’s premier healthcare institution, Weill Cornell Medicine is at the forefront of scientific research and clinical trials, enabling us to provide a full range of diagnostic and treatment protocols, including the latest breakthroughs in medicine.
Our team of internationally-recognized bone marrow transplant and stem cell specialists is known for advanced work and published research in:
· Treating patients with aggressive leukemia and myelodysplastic syndromes
· Bridge protocols for patients with refractory lymphoma and leukemia
· Novel strategies to mobilize stem cells and improve transplantation for patients with multiple myeloma, leukemia and lymphoma
We pride ourselves on exceptional outcomes and offer patients the most advanced diagnostic methods and treatment therapies to improve quality of life, including:
· Umbilical cord blood transplant
· Outpatient transplant
· Autologous stem cell transplant; uses stem cells extracted from the bone marrow or peripheral blood of the patient’s own blood
· Allogeneic stem cell transplant; uses stem cells extracted from the bone marrow or peripheral blood of a matching donor
· Hematopoietic stem cell transplant; used to treat certain cancers of the blood/bone marrow, including leukemia and myeloma
· Matched unrelated donor stem cell transplantation through the National Donor Matching Program
· Non-ablative "mini" transplants
· Haplo-Cord Transplant, allowing us to find donors for all patients, regardless of age or ethnic background
· Bendamustine, a therapy that is well-tolerated and has excellent response rates in patients with myeloma
Novel forms of transplant, offering hope and success to older patients with leukemia
Clinical trials are important to improve outcomes and offer new treatment options. At Weill Cornell Medicine, we conduct more studies in blood cancers than any of our regional peers, allowing us to provide our patients with access to many multi-phase clinical trials. As active members of the international cancer research community, our oncologists also collaborate with other research centers to offer patients the most promising treatments available.
View and search our database of open clinical trials.
In concert with your referring physician, we are always available to offer a second opinion in the form of a consultation with one of our specialists.
Why Choose Us?
Our collaborative approach means our patients receive supportive, comprehensive care and the most cutting-edge stem cell therapy and treatments. This enables patients to receive the best possible transplant outcomes. Additionally, we offer more allogeneic stem cell transplants for older adults than any other center in New York City and the entire tri-state area.
Located in New York City, Weill Cornell Medical College is ranked among the nation’s best by U.S. News & World Report year after year.